下一代 CAR-NK 细胞治疗:工程化策略、转化挑战与肿瘤免疫治疗的未来展望 Next-generation CAR-NK cell therapy: engineering strategies, translational challenges, and future perspectives in cancer immunotherapy. PubMed 2026/06/18 发表Cancer Cell IntQ1 · IF 7(JCR 2025) 技术:CAR-T技术:CAR-NK技术:NK 细胞血液系统恶性肿瘤实体瘤地区:其他
规划通往实体瘤的杀伤路径:在肿瘤微环境中招募并激活 NK 细胞的策略 Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment. PubMed 2023/11/08 发表Front ImmunolQ1 · IF 7(JCR 2025) 靶点:CD19技术:CAR-NK技术:NK 细胞技术:溶瘤病毒血液系统恶性肿瘤实体瘤
基因编辑和 CAR-NK 细胞:NK 细胞工程化用于免疫治疗的机遇与挑战 Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy. PubMed 2022/11/03 发表Mol Ther Oncolytics 技术:CAR-NK技术:NK 细胞技术:溶瘤病毒血液系统恶性肿瘤实体瘤地区:美国